围手术期COVID-19真的与更差的手术结局相关吗?一项全国性COVIDSurg倾向匹配分析
基于COVIDSurg国际多中心数据库中2020年2月至7月美国68家医院的患者,将围手术期COVID-19(术前7天内或术后30天内诊断)患者与2012年美国外科医师学会国家外科质量改进计划数据库中接受类似手术的无COVID-19患者按人口学、合并症和手术特征1:1倾向匹配。共纳入97,936例,匹配后各843例。匹配后COVID-19组30天死亡率更高(12.0% vs 8.1%,p=0.007),住院时间更长(6[2-15] vs 5[1-12]天),急性肾衰竭(19.3% vs 3.0%,p<0.001)、脓毒症(13.5% vs 9.0%,p=0.003)、脓毒性休克(11.8% vs 6.0%,p<0.001)、深静脉血栓(4.4% vs 1.5%,p<0.001)和肺栓塞(2.5% vs 0.4%,p<0.001)发生率更高,出血发生率更低(11.6% vs 26.1%,p<0.001)。作者认为该信息对复杂手术决策和患者咨询至关重要。证据等级为预后与流行病学,Level IV。
要点
- 匹配后围手术期COVID-19患者30天死亡率12.0% vs 8.1%(p=0.007),住院时间6[2-15] vs 5[1-12]天。
- 匹配后COVID-19组急性肾衰竭19.3% vs 3.0%(p<0.001)、脓毒症13.5% vs 9.0%(p=0.003)、脓毒性休克11.8% vs 6.0%(p<0.001)。
- 匹配后COVID-19组深静脉血栓4.4% vs 1.5%(p<0.001)、肺栓塞2.5% vs 0.4%(p<0.001),血栓栓塞并发症更高。
- 匹配后COVID-19组出血11.6% vs 26.1%(p<0.001),低于无COVID-19组。
- 匹配前COVID-19患者急诊手术比例76.1% vs 10.3%(p<0.001),提示存在选择偏倚。
适用人群与场景
- 2020年2月至7月美国68家医院中围手术期COVID-19(术前7天内或术后30天内诊断)并接受手术的患者,与2012年美国外科医师学会国家外科质量改进计划数据库中接受类似手术的无COVID-19患者进行1:1倾向匹配。
研究设计与关键结果
- 研究类型为基于COVIDSurg国际多中心数据库的倾向匹配分析,共纳入97,936例患者,其中1,054例有COVID-19、96,882例无COVID-19;匹配前COVID-19患者急诊手术比例更高(76.1% vs 10.3%,p<0.001)。
- 匹配后各843例,COVID-19组30天死亡率更高(12.0% vs 8.1%,p=0.007),住院时间更长(6[2-15] vs 5[1-12]天)。
- 匹配后COVID-19组急性肾衰竭(19.3% vs 3.0%,p<0.001)、脓毒症(13.5% vs 9.0%,p=0.003)、脓毒性休克(11.8% vs 6.0%,p<0.001)发生率更高。
- 匹配后COVID-19组深静脉血栓(4.4% vs 1.5%,p<0.001)和肺栓塞(2.5% vs 0.4%,p<0.001)发生率更高,出血发生率更低(11.6% vs 26.1%,p<0.001)。
证据类型、等级与局限
- 证据类型为预后与流行病学研究,证据等级Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,围手术期COVID-19患者30天死亡率和术后并发症(尤其是血栓栓塞)更高,该信息对复杂手术决策和患者咨询至关重要。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients undergoing surgery with perioperative COVID-19 are suggested to have worse outcomes, but whether this is COVID-related or due to selection bias remains unclear. We aimed to compare the postoperative outcomes of patients with and without perioperative COVID-19.
METHODS: Patients with perioperative COVID-19 diagnosed within 7 days before or 30 days after surgery between February and July 2020 from 68 US hospitals in COVIDSurg, an international multicenter database, were 1:1 propensity score matched to patients without COVID-19 undergoing similar procedures in the 2012 American College of Surgeons National Surgical Quality Improvement Program database. The matching criteria included demographics (e.g., age, sex), comorbidities (e.g., diabetes, chronic obstructive pulmonary disease, chronic kidney disease), and operation characteristics (e.g., type, urgency, complexity). The primary outcome was 30-day hospital mortality. Secondary outcomes included hospital length of stay and 13 postoperative complications (e.g., pneumonia, renal failure, surgical site infection).
RESULTS: A total of 97,936 patients were included, 1,054 with and 96,882 without COVID-19. Prematching, COVID-19 patients more often underwent emergency surgery (76.1% vs. 10.3%, p < 0.001). A total of 843 COVID-19 and 843 non-COVID-19 patients were successfully matched based on demographics, comorbidities, and operative characteristics. Postmatching, COVID-19 patients had a higher mortality (12.0% vs. 8.1%, p = 0.007), longer length of stay (6 [2-15] vs. 5 [1-12] days), and higher rates of acute renal failure (19.3% vs. 3.0%, p < 0.001), sepsis (13.5% vs. 9.0%, p = 0.003), and septic shock (11.8% vs. 6.0%, p < 0.001). They also had higher rates of thromboembolic complications such as deep vein thrombosis (4.4% vs. 1.5%, p < 0.001) and pulmonary embolism (2.5% vs. 0.4%, p < 0.001) but lower rates of bleeding (11.6% vs. 26.1%, p < 0.001).
CONCLUSION: Patients undergoing surgery with perioperative COVID-19 have higher rates of 30-day mortality and postoperative complications, especially thromboembolic, compared with similar patients without COVID-19 undergoing similar surgeries. Such information is crucial for the complex surgical decision making and counseling of these patients.
LEVEL OF EVIDENCE: Prognostic and Epidemiologic; Level IV.
参考来源
- Argandykov D, Dorken-Gallastegi A, El Moheb M, et al. Is perioperative COVID-19 really associated with worse surgical outcomes? A nationwide COVIDSurg propensity-matched analysis. J Trauma Acute Care Surg. 2023. PMID: 36949053. doi:10.1097/TA.0000000000003859
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。